脑机接口
Search documents
1.22犀牛财经早报:国际金价屡创新高 回调风险需警惕
Xi Niu Cai Jing· 2026-01-22 02:08
银行大额存单利率步入"0字头"时代 国际金价屡创新高 回调风险需警惕 大额存单利率步入"0字头"时代,银行正通过"短期化、高门槛、低利率"的组合策略开启负债端深度调 整。2026年开年,超40家银行发布的首期产品显示,1年期以下利率普遍跌破1%,3年期多低于2%,5 年期近乎绝迹,而百万元起存门槛产品悄然浮现。业内专家指出,这一结构性变化是银行业在净息差持 续低于1.5%的严峻压力下,为配合实体经济融资成本下行、实现自身稳健经营的必然选择。展望全 年,专家普遍认为,在适度宽松货币环境与银行息差压力持续的双重作用下,大额存单利率低位运行将 成常态,这标志着居民资产配置逻辑与银行负债管理模式正经历深刻重构。(经济参考报) 中金公司:2025年ETF市场增长空间充足 规模增速或放缓 中金公司研报指出,2025年ETF市场多点开花,规模与结构更为优化。总结来看,我们认为ETF市场无 论在长期维度还是今年都有较充足的增长空间,在公募整体市场内的份额还将继续上升,但今年的规模 增速或将继续放缓。同时结合资金流向与投资者结构的信息,我们认为无论对于宽基、行业主题、还是 跨境产品而言,资管机构资金的重要性都有明显提升,基金管 ...
重大突破!复旦团队:世界首款纤维芯片问世!
是说芯语· 2026-01-22 02:03
1月22日消息,据复旦大学公众号介绍,今天凌晨,国际顶级学术期刊《自然》主刊发表了复旦大学彭慧胜/陈培宁团队的最新研究成果《基于多层旋叠 架构的纤维集成电路》, 团队成功在柔软的高分子纤维内制造出大规模集成电路,创造出世界首款"纤维芯片"。 有望为脑机接口、电子织物、虚拟现实等新兴产业提供强有力的技术支撑。 "纤维芯片"概念图 柔软的"纤维芯片"在手指上打结照片 经过近五年时间,团队先后攻克了高分子表面平整化、耐溶剂侵蚀、形变下电路稳定等多个技术难题,最终成功制备出具有信息处理功能的"纤维芯 片"。 该"纤维芯片"不仅保持了纤维柔软、可编织的本征特性, 更实现了电阻、电容、二极管、晶体管等电子元件的高精度互连,光刻精度达到了实验室级光 刻机最高水平。 "纤维芯片"及其内部局部电路光学照片 这意味着,基于"纤维芯片", 未来可将发光、传感等模块直接集成在一根纤维上,形成无需外接设备的全闭环系统,甚至实现自供能。 据介绍,传统芯片的光刻工艺普遍依赖平整的硅晶圆衬底,而纤维不仅具有曲面结构,表面积极小,用于制备纤维器件的弹性高分子基底,也很难耐受光 刻过程中的各类极性溶剂。 同时还要保证在拉伸、扭转等变形中保持电路 ...
医保新规发布,手术机器人收费有了“国家标准”!医疗设备ETF(159873)昨日净流入近200万元,近10日累计“吸金”1.2亿元
Sou Hu Cai Jing· 2026-01-22 01:55
Group 1: ETF Performance - As of January 21, the Medical Equipment ETF (159873) saw a net subscription of 3 million units, with a turnover rate of 8.04% and a transaction volume of 18.88 million yuan [1] - The Medical Equipment ETF reached a new high with a total size of 379 million units [1] - The Medical Equipment ETF has experienced continuous net inflows over the past 10 days, totaling 119 million yuan [1] Group 2: Innovation Drug ETF Highlights - The Innovation Drug ETF Tianhong (517380) achieved a new size of 1.88 billion yuan and a total of 2.36 billion units, both marking new highs since its inception [2] - The Innovation Drug ETF has seen continuous net inflows for 12 days, accumulating 426 million yuan [3] Group 3: Market Trends and Events - A new guideline was released by the National Healthcare Security Administration on January 20, focusing on pricing for surgical robots and other medical services, establishing 37 pricing projects and 5 additional items [6] - The JPM 2026 conference highlighted the strength of Chinese innovative drugs, with significant collaborations between Chinese companies and multinational giants, indicating a shift from asset export to global participation [7] Group 4: Institutional Insights - According to Founder Securities, the implementation of the new pricing guideline will promote the clinical adoption of innovative technologies and drive demand for terminal equipment and surgical assistance [8] Group 5: Product Features - The Medical Equipment ETF (159873) has a high content of brain-computer interface stocks, accounting for over 19%, and includes nearly 80% of stocks from the Sci-Tech Innovation Board and the Growth Enterprise Market [4]
趋势研判!2026年中国智能设备行业发展历程、政策、发展现状、重点企业及未来趋势:全场景智能化生态加速形成,引领智能设备规模达万亿级别[图]
Chan Ye Xin Xi Wang· 2026-01-22 01:07
Core Insights - The smart device industry is experiencing significant growth driven by increasing consumer demand and advancements in technology, with the market size in China projected to grow from 5,133 billion yuan in 2018 to 17,157 billion yuan by 2024, representing a compound annual growth rate (CAGR) of 22.28% [1][14][15] - The industry is categorized into three main segments: smart home, smart wearables, and smart mobility, each with distinct applications and market dynamics [3][16][17] Industry Overview - Smart devices integrate hardware, software, and internet technologies, enabling them to perform tasks such as data collection and self-optimization [1][14] - The market is expected to reach 20,979 billion yuan by 2025, indicating continued growth and innovation in the sector [1][14] Industry Development Stages - The smart device industry in China has evolved through three phases: the initial stage (1990s to early 2000s), the development stage (2000 to 2015), and the explosive growth stage (2015 to present), with significant technological advancements and market expansion occurring in the latter two phases [6][8] Industry Policies - The Chinese government has implemented various policies to support the smart device industry, including initiatives to promote digital transformation and the development of smart products across multiple sectors [8][9] Industry Value Chain - The smart device industry value chain consists of upstream raw materials, hardware, and software systems; midstream manufacturing; and downstream applications in sectors such as healthcare, education, and transportation [10][11] Market Segmentation - The smart home market is characterized by diverse competition among traditional appliance manufacturers and tech companies, with a focus on integrated solutions and consumer experience [15] - The smart wearable segment includes products like smart glasses and smartwatches, with significant growth potential driven by consumer acceptance and technological advancements [16][17] - The smart mobility sector, particularly smart cars, is rapidly expanding, with the market size projected to grow from 777 billion yuan in 2020 to 2,152 billion yuan by 2024, reflecting a CAGR of 29% [17][18] Competitive Landscape - The smart device industry is marked by an ecosystem of competition, with leading companies leveraging core technologies and brand advantages to create comprehensive solutions across various applications [18][19] Future Trends - The industry is expected to see innovations in human-computer interaction, moving towards more natural and multi-modal interfaces [21] - There will be a shift from single-product intelligence to integrated scene intelligence, enhancing cross-device collaboration and user experience [22] - Smart devices will increasingly focus on personalized health management, evolving into digital health assistants capable of providing tailored recommendations [24]
纤维芯片:把大规模集成电路装进“头发丝”
Xin Lang Cai Jing· 2026-01-22 00:44
(来源:千龙网) 说起芯片,人们脑海中一般会浮现科技感十足的片状结构。 能否把它做成柔软的纤维状结构?"我们在大约10年前萌生了这个想法,觉得很有趣,就开始做了。"中 国科学院院士、复旦大学教授彭慧胜说。 经过多年攻关,彭慧胜和复旦大学教授陈培宁领衔的科研团队利用自主设计的多层旋叠架构,在弹性高 分子纤维内实现了大规模集成电路。为便于理解,团队给它取了个别名"纤维芯片"。1月22日,这项跳 出以往集成电路框架的研究成果发表于《自然》。 "有趣"之余,纤维芯片也很有用。它既有良好的信息处理能力,又有高度柔软、适应拉伸扭曲等复杂形 变、可编织等独特优势,有望为发展脑机接口、电子织物、虚拟现实等新兴产业提供有力支撑。 此外,与传统硬质芯片相比,纤维芯片还具有优异的柔性,可耐受弯曲、拉伸、扭曲等复杂形变,甚至 在经过上百次水洗、置于100摄氏度高温环境、卡车碾轧后,仍能保持性能稳定。 引领纤维器件领域 纤维器件是我国具有领先优势的领域之一,并引发国际学术界和产业界关注。而提出这一概念的,正是 彭慧胜团队。 自2008年成功研制"纤维变色器件"以来,彭慧胜团队在纤维器件领域持续深耕,迄今已创建出30多种具 有发电、储能 ...
未来已来,中国经济如何破浪向“新”
Xin Lang Cai Jing· 2026-01-22 00:44
科技创新之所以能成为驱动发展的引擎,根源在于其对供给与需求两端的双向牵引、协同赋能。一方 面,重大技术突破持续转化为具有市场竞争力的新产品、新业态,在供给端注入源源不断的新活力;另 一方面,人民群众对高品质生活的热切期盼,又为新技术、新服务开辟了广阔的应用场景,在需求端拓 展无限可能。 对普通人而言,科技创新并非遥不可及的宏观叙事,而是触手可及的生活体验。在黑龙江漠河,搭载超 低温高比能锂电池的无人机,在极寒环境下腾空而起;在北京亦庄,机器人在擂台上打拳击,其精准控 制与灵活协同让观众拍案叫绝;在浙江杭州,人工智能大模型走进熙攘的商业街区,为市民提供智慧便 捷的贴心服务……这些遍布神州大地的创新实践,生动诠释了科技创新从实验室走向生产线、从技术蓝 图变为现实生产力的蝶变之路。 未来已来,谁能将创新势能转化为发展优势,谁就能在风云变幻的国际竞争中牢牢掌握主动权。唯有紧 紧把握科技创新这个关键变量,以持续迸发的创新活力托举长远目标,中国经济才能开辟更多供奋斗者 驰骋的"蓝海"赛道,在时代浪潮中行稳致远、赢得主动。 回顾2025,中国经济"稳"的格局得到巩固,"进"的步伐更加有力,"新"的动能培育壮大,"韧"的特性 ...
脑机接口新突破 中文失语患者有望重获“新声”
Ren Min Ri Bao· 2026-01-21 23:47
中科院上海微系统与信息技术研究所供图 中科院上海微系统与信息技术研究所供图 语言脑机接口技术与人工智能和具身智能技术融合。 汉语语句实时解码。 近日,中国科学院上海微系统与信息技术研究所联合相关团队,在语言脑机接口领域取得突破性进展。 研究人员开发出植入式高通量柔性脑机接口系统和汉语言实时神经网络解码算法,并在国际上首次实现 脑机接口实时汉语解码和语句合成。这项研究不仅让中文失语患者有望重新"开口说话",也为脑机接口 在多语言、多场景下的应用打开了新空间。 覆盖全部发音组合,进而实现解码任意汉字和语句。 实现解码任意汉字和语句 语言是人与人之间沟通交流的主要形式。然而,脑卒中、渐冻症、脑外伤等重大脑疾病,常让患者失去 语言表达能力,陷入意识清醒却无法开口的困境。 "中国有近800万因各类脑疾病失去语言能力的患者,汉语解码对他们有着很大的意义和应用价值。"中 国科学院上海微系统与信息技术研究所研究员周志涛说,近年来,国际上的多个顶尖科研团队在脑机接 口英语解码上取得了多项突破性进展,包括英语和西班牙语双语解码,但是使用人数最多、与英语差异 很大的汉语解码研究由于起步较晚而进展相对慢。 周志涛说,团队此次研究的核 ...
“新字号”强壮记丨脑机接口点亮新医疗——翔宇医疗实现意念控物
He Nan Ri Bao· 2026-01-21 23:37
Core Insights - The article highlights the advancements in brain-computer interface (BCI) technology, particularly in rehabilitation medical devices, as demonstrated by Xiangyu Medical in Anyang, Henan province [1][2]. Company Overview - Xiangyu Medical is a leading enterprise in China's rehabilitation medical device industry, focusing on integrating cutting-edge technologies like BCI into their products [1]. - The company has successfully adapted 27 rehabilitation devices to BCI technology as of December 31, 2025, with a goal to reach nearly 100 devices by the end of 2026 [3]. Technology and Innovation - The BCI technology showcased includes non-invasive methods that convert brain signals into device commands, allowing users to control rehabilitation equipment through thought alone [1][2]. - The company emphasizes the safety and convenience of non-invasive BCI compared to invasive methods, which require surgical implantation and carry higher risks and costs [2]. Industry Context - The domestic BCI industry is experiencing rapid technological advancements and expanding application scenarios, with both invasive and non-invasive approaches being developed [2]. - Xiangyu Medical collaborates with 62 upstream and downstream companies within the rehabilitation equipment industry park in Neihuang County, creating a comprehensive industrial chain that supports research, manufacturing, and service [3]. Future Goals - The company aims to establish a complete brain-controlled rehabilitation ecosystem by integrating mainstream rehabilitation devices with BCI technology over the next five years [3]. - Xiangyu Medical is committed to accelerating the clinical application of BCI products to benefit patients, leveraging its extensive experience in industry-academia-research collaboration [3].
不同类型企业都能享有政策红利
Xin Hua Ri Bao· 2026-01-21 23:23
Group 1 - The core viewpoint of the news is the introduction of eight supportive policies aimed at enhancing enterprise development in Jiangsu Province, combining both existing and new financial support measures [1][2][3] - The manufacturing loan interest subsidy policy has been optimized and expanded, allowing two types of enterprises to directly benefit from interest subsidies, specifically "C manufacturing" enterprises and recognized "little giant" enterprises [1] - The modern service industry loan interest subsidy policy has seen improvements, with a budget of 150 million yuan for 2026, increasing the subsidy rate from 1% to 1.5%, and expanding the eligible sectors to include various service industries [2] Group 2 - Jiangsu has implemented a "fiscal + financial" strategy to address enterprise financing challenges, resulting in significant financial support for sectors such as technology innovation and advanced manufacturing [3] - The province has introduced a comprehensive framework of 20 measures and over 60 policy points to support high-quality economic development, with 4.6 billion yuan allocated for fiscal subsidies [3] - The policies aim to leverage financial resources, with over 600 billion yuan mobilized to support various sectors, including small and micro enterprises [3]
脑机接口点亮新医疗(“新字号”强壮记)
He Nan Ri Bao· 2026-01-21 22:39
Core Insights - The article highlights the advancements in brain-computer interface (BCI) technology, particularly in rehabilitation medical devices, as demonstrated by Xiangyu Medical Equipment Co., Ltd. [1][2] Company Overview - Xiangyu Medical is a leading enterprise in China's rehabilitation medical device industry, focusing on innovative technologies such as brain-computer interfaces [1]. - The company has successfully adapted 27 rehabilitation devices to BCI technology as of December 31, 2025, with a goal to achieve nearly 100 BCI-enabled rehabilitation devices by the end of 2026 [3]. Technology Development - The BCI industry in China is experiencing rapid technological iteration and expanding application scenarios, with both invasive and non-invasive technologies being developed [2]. - Non-invasive BCI technology, which uses devices like EEG caps to collect brain signals, is considered safer and more convenient for large-scale promotion in rehabilitation and health management [2]. Industry Collaboration - Xiangyu Medical collaborates with 62 upstream and downstream companies within the rehabilitation equipment industrial park in Neihuang County, creating a complete industrial chain that includes research, manufacturing, and service [3]. - The company aims to accelerate the transformation of innovative results into clinical applications through collaborative innovation and established market channels [3].